Intel Corporation vs Johnson & Johnson: Strategic Comparison
Key Differences at a Glance
| Field | Intel Corporation | Johnson & Johnson |
|---|---|---|
| Revenue | $52.9B | $94.2B |
| Founded | 1968 | 1886 |
| Employees | 85,100 | 140,800 |
| Market Cap | $536.6B | $612.8B |
| Headquarters | United States | United States |
Quick Stats Comparison
| Metric | Intel Corporation | Johnson & Johnson |
|---|---|---|
| Revenue | $52.9B | $94.2B |
| Founded | 1968 | 1886 |
| Headquarters | Santa Clara, California | New Brunswick, New Jersey |
| Market Cap | $536.6B | $612.8B |
| Employees | 85,100 | 140,800 |
Intel Corporation Revenue vs Johnson & Johnson Revenue — Year by Year
| Year | Intel Corporation | Johnson & Johnson | Leader |
|---|---|---|---|
| 2025 | $52.9B | $94.2B | Johnson & Johnson |
| 2024 | $53.1B | $88.8B | Johnson & Johnson |
| 2023 | $54.2B | $85.2B | Johnson & Johnson |
| 2022 | $63.1B | N/A | Intel Corporation |
| 2021 | $79.0B | N/A | Intel Corporation |
Business Model Breakdown
Overview: Intel Corporation vs Johnson & Johnson
This in-depth comparison examines Intel Corporation and Johnson & Johnson across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching Intel Corporation on its own, evaluating Johnson & Johnson, or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between Intel Corporation and Johnson & Johnson is widest.
On the headline numbers, Intel Corporation reports annual revenue of $52.9B against $94.2B for Johnson & Johnson, while their respective market capitalizations stand at $536.6B and $612.8B. Intel Corporation is headquartered in United States and Johnson & Johnson operates from United States, and those different home markets shape how each company competes.
Intel Corporation: Intel is no longer just a PC chip company. It is a turnaround story at the intersection of semiconductor design, national manufacturing strategy, data-center competition, and AI infrastructure.
Johnson & Johnson: Johnson & Johnson began as a medical-products company in the nineteenth century and became a diversified healthcare giant. After the Kenvue separation, it is a more focused healthcare company centered on medicine and medical technology.
Business Models: How Intel Corporation and Johnson & Johnson Make Money
Intel Corporation and Johnson & Johnson pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between Intel Corporation and Johnson & Johnson.
Intel Corporation business model: Intel earns revenue from Client Computing Group, Data Center and AI, Network and Edge, Mobileye, and Intel Foundry. The model is capital intensive because Intel owns fabs, develops process nodes, and must fund both product design and manufacturing technology.
Johnson & Johnson business model: Johnson & Johnson makes money by discovering, developing, manufacturing, and selling prescription medicines and medical technologies. Innovative Medicine sells therapies in oncology, immunology, neuroscience, pulmonary hypertension, infectious disease, and cardiovascular/metabolism. MedTech sells surgery, orthopaedics, cardiovascular, and vision products to hospitals, physicians, and healthcare systems.
Competitive Advantage: Intel Corporation vs Johnson & Johnson
The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of Intel Corporation stack up against those of Johnson & Johnson.
Intel Corporation competitive advantage: Intel's advantage is still its x86 ecosystem, deep enterprise relationships, installed base, advanced packaging, U.S. manufacturing footprint, and potential strategic value as a geographically diversified foundry.
Johnson & Johnson competitive advantage: Johnson & Johnson's advantage comes from scale, R&D depth, global regulatory capability, major oncology and immunology franchises, MedTech breadth, and a large commercial infrastructure.
Growth Strategy: Where Intel Corporation and Johnson & Johnson Are Headed
Future prospects matter as much as current results. The growth strategies below explain how Intel Corporation and Johnson & Johnson each plan to expand from here.
Intel Corporation growth strategy: Intel is trying to restore product leadership, ramp advanced process nodes, win foundry customers, improve cost discipline, expand advanced packaging, and focus the portfolio under Lip-Bu Tan.
Johnson & Johnson growth strategy: The company is investing in oncology, immunology, neuroscience, cardiovascular MedTech, electrophysiology, surgery, R&D, acquisitions, and global commercial execution.
Financial Picture: Intel Corporation vs Johnson & Johnson
A closer look at the financial trajectory of Intel Corporation and Johnson & Johnson rounds out the comparison.
Intel Corporation: Intel reported $52.853B in 2025 revenue and a $267M net loss attributable to Intel. Revenue was roughly flat, but profitability improved sharply from the 2024 restructuring-heavy loss.
Johnson & Johnson: Johnson & Johnson's FY2025 sales increased 6.0% to $94.193 billion. Net earnings rose to $26.804 billion, helped by operating performance and other income items. Innovative Medicine generated $60.401 billion in sales, while MedTech generated $33.792 billion.
Company-Specific SWOT Notes
Intel Corporation
Intel Corporation's main strength is Intel's advantage is its x86 installed base, manufacturing know-how, enterprise relationships, packaging technology, and strategic importance to domestic chip supply.
Intel Corporation has $52.
Intel Corporation's main watchpoint is Major exposures are foundry execution, AI accelerator competition, capital intensity, margin pressure, and share loss to AMD and ARM-based designs.
Intel Corporation's model depends on continued execution in semiconductors and can be pressured by pricing, regulation, capital intensity, or customer demand shifts.
Intel Corporation's current growth strategy is: Intel is trying to rebuild process leadership, scale Intel Foundry, simplify operations, and compete in AI PCs, servers, accelerators, and advanced packaging.
Intel Corporation competes with Advanced Micro Devices, Inc.
Johnson & Johnson
Johnson & Johnson's advantage comes from scale, R&D depth, global regulatory capability, major oncology and immunology franchises, MedTech breadth, and a large commercial infrastructure.
Johnson & Johnson wins through medical trust, R&D scale, global reach, leading drug franchises, MedTech breadth, and commercial execution.
The biggest risk is patent, pricing, litigation, or R&D pressure that weakens growth in key pharmaceutical and MedTech franchises.
The company is investing in oncology, immunology, neuroscience, cardiovascular MedTech, electrophysiology, surgery, R&D, acquisitions, and global commercial execution.
Head-to-Head Scorecard
| Category | Winner | Why |
|---|---|---|
| Revenue Scale | Johnson & Johnson | Johnson & Johnson reports the larger revenue base ($94.2B), which serves as a core operational scale signal. |
| Profitability Potential | Comparable | Both organizations prioritize market penetration or are at equivalent reporting tiers. |
| Company Age | Johnson & Johnson | Founded in 1968 vs 1886. The earlier pioneer typically commands longer historical institutional legacy. |
| Innovation Moat | Intel Corporation | Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity. |
| Scale (Employees) | Johnson & Johnson | A significantly larger reported workforce supports enhanced global distribution capability. |
| Market Cap | Johnson & Johnson | Higher public valuation denotes greater forward-looking investor conviction in earnings potential. |
| Future Outlook | Tied | Strategic auditing assesses that both maintain defensive leadership vectors within their core market clusters. |
Who Wins Each Category?
Johnson & Johnson reports the larger revenue base ($94.2B), which serves as a core operational scale signal.
Both organizations prioritize market penetration or are at equivalent reporting tiers.
Founded in 1968 vs 1886. The earlier pioneer typically commands longer historical institutional legacy.
Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity.
A significantly larger reported workforce supports enhanced global distribution capability.
Who Wins: Intel Corporation or Johnson & Johnson?
Reviewed by Swet Parvadiya, May 2026 - Author Profile
Our analysts compile business strategy profiles from public financial filings, press releases, and analyst reports. Each profile is reviewed for accuracy before publication by our editorial desk and updated on a rolling basis.
Frequently Asked Questions: Intel Corporation vs Johnson & Johnson
Is Intel Corporation better than Johnson & Johnson?
Verdict: Between Intel Corporation and Johnson & Johnson, Johnson & Johnson is the stronger overall option based on higher annual revenue. The decision still depends on which factors matter most for your needs, but on the weight of the evidence above, Johnson & Johnson comes out ahead in this Intel Corporation vs Johnson & Johnson comparison.
Who earns more — Intel Corporation or Johnson & Johnson?
Johnson & Johnson earns more with $94.2B in annual revenue versus Intel Corporation's $52.9B. Johnson & Johnson leads on total revenue based on latest verified figures.
Which company has higher revenue — Intel Corporation or Johnson & Johnson?
Intel Corporation reported $52.9B, while Johnson & Johnson reported $94.2B. The revenue leader is Johnson & Johnson based on latest verified figures.
Intel Corporation revenue vs Johnson & Johnson revenue — which is higher?
Intel Corporation revenue: $52.9B. Johnson & Johnson revenue: $52.9B. Johnson & Johnson has the larger revenue base of the two companies.
Sources & References
- SEC EDGAR: Intel Corporation Annual Filings (10-K, 8-K)
- Intel Corporation Corporate Website
- Intel Corporation Annual Report 2025 - Revenue and Financial Data
- sec.gov
- sec.gov
- sec.gov
- intc
- intel.com
- intel.com
- intel.com
- newsroom.intel.com
- data.sec.gov
- sec.gov
- data.sec.gov
- intel.com
- finance.yahoo.com
- SEC EDGAR: Johnson & Johnson Annual Filings (10-K, 8-K)
- Johnson & Johnson Corporate Website
- Johnson & Johnson Annual Report 2025 - Revenue and Financial Data
- sec.gov